Ignite Creation Date:
2024-05-05 @ 5:08 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00399542
Status:
COMPLETED
Last Update Posted:
2019-12-17
First Post:
2006-11-13
Brief Title:
Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With Constipation
Sponsor:
Sucampo Pharma Americas LLC
Organization:
Mallinckrodt
Organization Data
Organization:
Mallinckrodt
Class:
INDUSTRY
Study ID:
0211SIB-0432
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sucampo Pharma Americas LLC
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Sucampo Pharmaceuticals Inc | INDUSTRY |